OpenURL Connection Search

Select item for more details and to access through your institution.

STATISTICAL ANALYSIS OF WIND SPEED FOR ELECTRICAL POWER GENERATION IN SOME SELECTED SITES IN NORTHERN NIGERIA.
Published in:
Nigerian Journal of Technology, 2017, v. 36, n. 4, p. 1249, doi. 10.4314/njt.v36i4.35
By:
- Abdulkarim, A.;
- Abdelkader, S. M.;
- Morrow, D. J.;
- Falade, A. J.;
- Adediran, Y. A.
Publication type:
Article
Prostacyclin and thromboxane changes predating clinical onset of preeclampsia: a multicenter prospective study.
Published in:
1999
By:
- Mills, James L.;
- DerSimonian, Rebecca;
- Raymond, Elizabeth;
- Morrow, Jason D.;
- Roberts II, L. Jackson;
- Clemens, John D.;
- Hauth, John C.;
- Catalano, Patrick;
- Sibai, Baha;
- Curet, L.B.;
- Levine, Richard J.;
- Mills, J L;
- DerSimonian, R;
- Raymond, E;
- Morrow, J D;
- Roberts, L J 2nd;
- Clemens, J D;
- Hauth, J C;
- Catalano, P;
- Sibai, B
Publication type:
journal article
Biomarker responses and disease susceptibility in juvenile rainbow trout Oncorhynchus mykiss fed a high molecular weight PAH mixture.
Published in:
Environmental Toxicology & Chemistry, 2011, v. 30, n. 3, p. 704, doi. 10.1002/etc.439
By:
- Bravo, C. F.;
- Curtis, L. R.;
- Myers, M. S.;
- Meador, J. P.;
- Johnson, L. L.;
- Buzitis, J.;
- Collier, T. K.;
- Morrow, J. D.;
- Laetz, C. A.;
- Loge, F. J.;
- Arkoosh, M. R.
Publication type:
Article
Low-sodium DASH reduces oxidative stress and improves vascular function in salt-sensitive humans.
Published in:
Journal of Human Hypertension, 2009, v. 23, n. 12, p. 826, doi. 10.1038/jhh.2009.32
By:
- Al-Solaiman, Y.;
- Jesri, A.;
- Zhao, Y.;
- Morrow, J. D.;
- Egan, B. M.
Publication type:
Article
EFFECTS OF PV AND BATTERY STORAGE TECHNOLOGIES ON THE OPTIMAL SIZING OF RENEWABLE ENERGY MICROGRID.
Published in:
Acta Technica Corviniensis - Bulletin of Engineering, 2018, v. 11, n. 3, p. 11
By:
- ABDULKARIM, A.;
- ABDELKADER, S. M.;
- MORROW, D. J.;
- AMUDA, SAY;
- MADUGU, I. S.;
- FALADE, A. J.;
- SAMINU, S.;
- ADEDIRAN, Y. A.
Publication type:
Article
Why the United States Still Needs Improved Dietary Supplement Regulation and Oversight.
Published in:
Clinical Pharmacology & Therapeutics, 2008, v. 83, n. 3, p. 391, doi. 10.1038/sj.clpt.6100500
By:
- Morrow, J. D.
Publication type:
Article
PII-5.
Published in:
Clinical Pharmacology & Therapeutics, 2006, v. 79, n. 2, p. P36, doi. 10.1016/j.clpt.2005.12.130
By:
- Milne, G. L.;
- Musiek, E. S.;
- Zanoni, G.;
- Vidari, G.;
- McLaughlin, B.;
- Morrow, J. D.
Publication type:
Article
PII-10.
Published in:
Clinical Pharmacology & Therapeutics, 2006, v. 79, n. 2, p. P38, doi. 10.1016/j.clpt.2005.12.135
By:
- Gao, L.;
- Freeman, M. L.;
- Morrow, J. D.
Publication type:
Article
PII-11.
Published in:
Clinical Pharmacology & Therapeutics, 2006, v. 79, n. 2, p. P38, doi. 10.1016/j.clpt.2005.12.136
By:
- Yin, H.;
- Porter, N.;
- Morrow, J. D.
Publication type:
Article
PII-14.
Published in:
Clinical Pharmacology & Therapeutics, 2006, v. 79, n. 2, p. P39, doi. 10.1016/j.clpt.2005.12.139
By:
- Brooks, J. D.;
- Yin, H.;
- Milne, G. L.;
- Morrow, J. D.
Publication type:
Article
Effects of flexible-dose fesoterodine on overactive bladder symptoms and treatment satisfaction: an open-label study.
Published in:
International Journal of Clinical Practice, 2009, v. 63, n. 4, p. 560, doi. 10.1111/j.1742-1241.2009.02035.x
By:
- Wyndaele, J.-J.;
- Goldfischer, E. R.;
- Morrow, J. D.;
- Gong, J.;
- Tseng, L.-J.;
- Guan, Z.;
- Choo, M.-S.
Publication type:
Article
Infants with myelomeningocele: visual recognition memory and sensorimotor abilities.
Published in:
1992
By:
- Morrow, Judy D.;
- Wachs, Theodore D.;
- Morrow, J D;
- Wachs, T D
Publication type:
journal article
Oxidative stress in systemic lupus erythematosus: relationship to disease activity and symptoms.
Published in:
Lupus, 2007, v. 16, n. 3, p. 195, doi. 10.1177/0961203306075802
By:
- Avalos, I.;
- Chung, C. P.;
- Oeser, A.;
- Milne, G. L.;
- Morrow, J. D.;
- Gebretsadik, T.;
- Shintani, A.;
- Yu, C.;
- Stein, C. M.
Publication type:
Article
Effect of pharmacological lowering of plasma urate on exercise-induced oxidative stress.
Published in:
Applied Physiology, Nutrition & Metabolism, 2007, v. 32, n. 6, p. 1148, doi. 10.1139/H07-131
By:
- McAnulty, S. R.;
- Hosick, P. A.;
- McAnulty, L. S.;
- Quindry, J. C.;
- Still, L.;
- Hudson, M. B.;
- Dibarnardi, A. N.;
- Milne, G. L.;
- Morrow, J. D.;
- Austin, M. D.
Publication type:
Article
Treatment of Cardiac Arrhythmias with Synchronized Electrical Countershock.
Published in:
Canadian Medical Association Journal, 1964, v. 90, n. 3, p. 103
By:
- BROWN, K. W. G.;
- WHITEHEAD, E. H.;
- MORROW, J. D.
Publication type:
Article
Products of the isoprostane pathway: unique bioactive compounds and markers of lipid peroxidation.
Published in:
Cellular & Molecular Life Sciences, 2002, v. 59, n. 5, p. 808, doi. 10.1007/s00018-002-8469-8
By:
- Roberts II., L. Jackson;
- Morrow, J. D.
Publication type:
Article
Nitric oxide synthesis and isoprostane production in subjects with type 1 diabetes and normal urinary albumin excretion.
Published in:
2000
By:
- O'Byrne, Sharon;
- Forte, Pablo;
- Roberts II, L. Jackson;
- Morrow, Jason D.;
- Johnston, Atholl;
- Anggard, Eric;
- Leslie, R.D.G.;
- Benjamin, Nigel;
- O'Byrne, S;
- Forte, P;
- Roberts, L J 2nd;
- Morrow, J D;
- Johnston, A;
- Anggård, E;
- Leslie, R D;
- Benjamin, N
Publication type:
journal article
Assessment of oxidant stress in allergic asthma by measurement of the major urinary metabolite of F2-isoprostane, 15-F2t-IsoP (8-iso-PGF2α).
Published in:
Clinical & Experimental Allergy, 2001, v. 31, n. 3, p. 387, doi. 10.1046/j.1365-2222.2001.01055.x
By:
- Dworski, R.;
- Jackson Roberts Ii, L.;
- Murray, J. J.;
- Morrow, J. D.;
- Hartert, T. V.;
- Sheller, J. R.
Publication type:
Article
No difference in plasma or urinary F2-isoprostanes among patients with Huntington's disease or Alzheimer's disease and controls.
Published in:
Annals of Neurology, 2000, v. 48, n. 6, p. 950, doi. 10.1002/1531-8249(200012)48:6<950::AID-ANA23>3.0.CO;2-F
By:
- Montine, T. J.;
- Shinobu, L.;
- Montine, K. S.;
- Roberts, L. J.;
- Kowall, N. W.;
- Beal, M. F.;
- Morrow, J. D.
Publication type:
Article
Cerebrospinal fluid F2-isoprostane levels are increased in Alzheimer's disease.
Published in:
Annals of Neurology, 1998, v. 44, n. 3, p. 410, doi. 10.1002/ana.410440322
By:
- Montine, T. J.;
- Markesbery, W. R.;
- Morrow, J. D.;
- Roberts, L. J.
Publication type:
Article

Found: 20

STATISTICAL ANALYSIS OF WIND SPEED FOR ELECTRICAL POWER GENERATION IN SOME SELECTED SITES IN NORTHERN NIGERIA.

Prostacyclin and thromboxane changes predating clinical onset of preeclampsia: a multicenter prospective study.

Biomarker responses and disease susceptibility in juvenile rainbow trout Oncorhynchus mykiss fed a high molecular weight PAH mixture.

Low-sodium DASH reduces oxidative stress and improves vascular function in salt-sensitive humans.

EFFECTS OF PV AND BATTERY STORAGE TECHNOLOGIES ON THE OPTIMAL SIZING OF RENEWABLE ENERGY MICROGRID.

Why the United States Still Needs Improved Dietary Supplement Regulation and Oversight.

PII-5.

PII-10.

PII-11.

PII-14.

Effects of flexible-dose fesoterodine on overactive bladder symptoms and treatment satisfaction: an open-label study.

Infants with myelomeningocele: visual recognition memory and sensorimotor abilities.

Oxidative stress in systemic lupus erythematosus: relationship to disease activity and symptoms.

Effect of pharmacological lowering of plasma urate on exercise-induced oxidative stress.

Treatment of Cardiac Arrhythmias with Synchronized Electrical Countershock.

Products of the isoprostane pathway: unique bioactive compounds and markers of lipid peroxidation.

Nitric oxide synthesis and isoprostane production in subjects with type 1 diabetes and normal urinary albumin excretion.

Assessment of oxidant stress in allergic asthma by measurement of the major urinary metabolite of F<sub>2</sub>-isoprostane, 15-F<sub>2t</sub>-IsoP (8-iso-PGF<sub>2α</sub>).

No difference in plasma or urinary F<sub>2</sub>-isoprostanes among patients with Huntington's disease or Alzheimer's disease and controls.

Cerebrospinal fluid F<sub>2</sub>-isoprostane levels are increased in Alzheimer's disease.